How Repurposed COVID Tests Offer Accurate Coagulation Status Evaluation
Researchers repurposed COVID rapid antigen tests for coagulation status evaluation using lateral flow assays combined with machine learning.
Researchers repurposed COVID rapid antigen tests for coagulation status evaluation using lateral flow assays combined with machine learning.
This month's issue features a fluid handling device from Tecan, a UV enclosure from Advanced Ultra-Violet Systems, and a molecular panel from BD.
This month's Product Spotlight features tools for hematology, blood banking, and biorepositories from such companies as Beckman Coulter, Hemo Bioscience, Ortho Clinical Diagnostics, and Sebia.
Tools to help manage testing volume quickly, efficiently, and cost-effectively are in demand.
Read MoreLeveraging preanalytical sample integrity technology, the system automates and standardizes sample management, detecting unsuitable samples prior to analysis.
Read MoreBio/Data Corporation • Helena Laboratories • Siemens Healthcare Diagnostics
Read MoreAcceptance of point-of-care testing grows as the tests’ performance improves
Read MoreRoche will expand its coagulation testing product line with the development of a full line of coagulation analyzers for hospital and reference laboratories.
Read MoreAlere IncBeckman Coulter IncDiagnostica Stago IncHelenaLaboratoriesSiemens HealthcareDiagnostics
Read MoreTrinity Biotech plc announced that it had closed its deal to dispose of its coagulation business to the Stago Group.
Read MoreThe Coagulation Analyzer survey is available as a downloadable pdf – you will need Adobe Acrobat reader to view this. If you do not have Adobe Acrobat on your computer, you can download it for free from Adobe.com.
Read MoreIntegrated analyzing software and robust devices increase precision while reducing analysis time.
Read MoreBeckman Coulter, Siemens Healthcare Diagnostics
Read MoreNew applications and extended medication times drive the growing coagulation analyzer market.
Read MoreDade Behring Inc has signed a license agreement with Radboud University Nijmegen Medical Centre (RUNMC), giving Dade Behring the exclusive rights for a new coagulation test called the Nijmegen Hemostasis Assay (NHA).
Read MoreFor most of the 12 million patients in the United States who receive it each year, heparin—applied through injections or infusions—is usually effective at preventing the formation of clots and the extension of
Read MoreDade Behring Inc has announced that it has introduced the capability to connect the Sysmex® CA-7000 Coagulation Analyzer to the StreamLAB® Analytical Workcell, one of the company’s customized automation solutions for the clinical laboratory.
Read MoreFor prothrombin time testing
Read More